Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
Abstract: Scoring functions (SFs), which measure the plausibility of triplets in knowledge graph (KG), have become the crux of KG embedding. Lots of SFs, which target at capturing different kinds of ...
Abstract: The mechanical properties of cells are known to be a label-free, inherent marker of biological function in health and disease. Wide-spread utilization has so far been impeded by the lack of ...